|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 7
Zeitschriftenartikel
Kaeuferle, Theresa; Stief, Tanja A; Canzar, Stefan; Kutlu, Nayad N; Willier, Semjon; Stenger, Dana; Ferrada‐Ernst, Paulina; Habjan, Nicola; Peters, Annika E; Busch, Dirk H und Feuchtinger, Tobias
(23. Januar 2022):
Genome‐wide off‐target analyses of CRISPR/Cas9‐mediated T‐cell receptor engineering in primary human T cells.
In: Clinical & Translational Immunology, Bd. 11, Nr. 1
[PDF, 2MB]
Blaeschke, Franziska; Ortner, Eva; Stenger, Dana; Mahdawi, Jasmin; Apfelbeck, Antonia; Habjan, Nicola; Weisser, Tanja; Käuferle, Theresa; Willier, Semjon; Kobold, Sebastian und Feuchtinger, Tobias
(2022):
Design and Evaluation of TIM-3-CD28 Checkpoint Fusion Proteins to Improve Anti-CD19 CAR T-Cell Function.
In: Frontiers in Immunology, Bd. 13
[PDF, 2MB]
Willier, Semjon; Rothamel, Paula; Hastreiter, Maximilian; Wilhelm, Jonas; Stenger, Dana; Blaeschke, Franziska; Rohlfs, Meino; Kaeuferle, Theresa; Schmid, Irene; Albert, Michael H.; Binder, Vera; Subklewe, Marion; Klein, Christoph und Feuchtinger, Tobias
(2021):
CLEC12A and CD33 coexpression as a preferential target for pediatric AML combinatorial immunotherapy.
In: Blood, Bd. 137, Nr. 8: S. 1037-1049
Blaeschke, Franziska; Willier, Semjon; Stenger, Dana; Lepenies, Mareike; Horstmann, Martin A.; Escherich, Gabriele; Zimmermann, Martin; Ringeling, Francisca Rojas; Canzar, Stefan; Kaeuferle, Theresa; Rohlfs, Meino; Binder, Vera; Klein, Christoph und Feuchtinger, Tobias
(2020):
Leukemia-induced dysfunctional TIM-3(+)CD4(+) bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patients.
In: Leukemia, Bd. 34, Nr. 10: S. 2607-2620
Willier, Semjon; Raedler, Johannes; Blaeschke, Franziska; Stenger, Dana; Escudero, Montserrat Pazos; Jurgeleit, Florian; Grunewald, Thomas G. P.; Binder, Vera; Schmid, Irene; Albert, Michael H.; Wolf, Armin und Feuchtinger, Tobias
(2020):
Leukemia escape in immune desert: intraocular relapse of pediatric pro-B-ALL during systemic control by CD19-CAR T cells.
In: Journal for Immunotherapy of Cancer, Bd. 8, Nr. 2, e001052
Stenger, Dana; Stief, Tanja A.; Kaeuferle, Theresa; Willier, Semjon; Rataj, Felicitas; Schober, Kilian; Vick, Binje; Lotfi, Ramin; Wagner, Beate; Grünewald, Thomas G. P.; Kobold, Sebastian; Busch, Dirk H.; Jeremias, Irmela; Blaeschke, Franziska und Feuchtinger, Tobias
(2020):
Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR.
In: Blood, Bd. 136, Nr. 12: S. 1407-1418
Blaeschke, Franziska; Stenger, Dana; Kaeuferle, Theresa; Willier, Semjon; Lotfi, Ramin; Kaiser, Andrew Didier; Assenmacher, Mario; Doering, Michaela; Feucht, Judith und Feuchtinger, Tobias
(2018):
Induction of a central memory and stem cell memory phenotype in functionally active CD4(+) and CD8(+) CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19(+) acute lymphoblastic leukemia.
In: Cancer Immunology Immunotherapy, Bd. 67, Nr. 7: S. 1053-1066